Published in Virologie on May 08, 1978
Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol (2000) 1.63
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
There is a palliative Europe to build/1st Congress of the European Association of Palliative Care. J Palliat Care (1990) 1.39
Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer (1995) 1.29
Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.28
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
Polymorphism of the HLA-D region in American blacks. A DR3 haplotype generated by recombination. J Immunol (1988) 1.19
Intestinal enterokinase. Mechanisms of tts "secretion" into the lumen of the small intestine. Lancet (1971) 1.17
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J (2001) 1.05
Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis (1992) 1.02
Correlations between anti-albumin antibodies and HBsAG in hepatic patients. J Med Virol (1977) 1.01
Methods for detection of anti-albumin autoantibodies in hepatic diseases. J Immunol Methods (1977) 1.00
Autoantibodies detected in rabbits hyperimmunized with group A, C, and G streptococcal vaccines. Infect Immun (1977) 0.96
Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol (1998) 0.95
Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation. J Immunol (2001) 0.94
Receptors for polymerized albumin on liver cells. Experientia (1977) 0.94
Persistent productive HIV infection in EBV-transformed B lymphocytes. J Med Virol (1989) 0.93
Effects of eccentric exercise on the immune system in men. J Appl Physiol (1985) (1999) 0.92
Immunogenicity of glutaraldehyde-treated homologous albumin in rabbits. Immunochemistry (1978) 0.90
Deeper insight into HBsAg--anti-albumin antibody correlations. J Med Virol (1979) 0.87
Physiological assessment of severe chronic asthma in children. Respiration (1978) 0.84
DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2004) 0.84
Morphohistological analysis and histochemistry of Feijoa sellowiana somatic embryogenesis. Protoplasma (2004) 0.83
Beclomethasone dipropionate aerosol for asthmatic children requiring maintenance oral steroid therapy. Med J Aust (1976) 0.83
Autoantibodies to the basal cells of squamous epithelium react with thymic epithelial cells. Clin Immunol Immunopathol (1985) 0.83
Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty. Clin Sci (Lond) (2002) 0.80
Anti-polymerized albumin antibodies-a test for the evaluation of hepatic function in HBs Ag-positive subjects. Virologie (1977) 0.80
Malignant B-cells have receptors for and respond to interleukin-2. Med Oncol Tumor Pharmacother (1986) 0.80
Specificity of anti-albumin autoantibodies in liver diseases. Mol Immunol (1981) 0.79
Autoantibodies against the basal cell layer: an association with chronic hepatitis B. Clin Immunol Immunopathol (1983) 0.79
Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection. AIDS Res Hum Retroviruses (2001) 0.79
Autoantibodies to thymic epithelial cells in hepatitis B virus-associated delta infection. J Infect Dis (1985) 0.79
A new antigen/antibody system--the polymerized albumin and antialbumin antibodies. Med Interne (1980) 0.78
Immunogenicity of glutaraldehyde treated homologous monomeric albumin in rabbits. Immunochemistry (1978) 0.78
Sequence of an HLA-B56 variant (B*5604) identified in the Korean population. Tissue Antigens (1998) 0.77
Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing. Tissue Antigens (1997) 0.77
Urinary excretion of albumin and beta 2-microglobulin in a population from an area where Balkan nephropathy is endemic. Scand J Clin Lab Invest (1977) 0.77
[Predictive factors of resistance to treatment of neuropathic pain]. Schweiz Med Wochenschr (1994) 0.77
The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. Hum Immunol (1989) 0.77
Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment. Liver (1992) 0.76
Seventeen more novel HLA-A locus alleles. Tissue Antigens (2000) 0.76
Differences in peptide binding of DR11 and DR13 microvariants demonstrate the power of minor variation in generating DR functional diversity. Hum Immunol (1995) 0.76
Novel HLA-A locus alleles including A*01012, A*0306, A*0308, A*2616, A*2617, A*3009, A*3206, A*3403, A*3602 and A*6604. Tissue Antigens (2002) 0.76
Radioimmunoassay of anti-albumin autoantibodies in human sera. J Immunol Methods (1981) 0.76
Anti-albumin antibodies in chronic liver diseases: diagnostic significance of these antibodies in patients with conventional or immunosuppressive therapy. Clin Exp Immunol (1981) 0.75
Viral hepatitis in Bucharest. Bull World Health Organ (1993) 0.75
[Significance of immuno-serological studies in chronic hepatopathies]. Physiologie (1978) 0.75
Visual-field measurements and driving eligibility. J Am Optom Assoc (1997) 0.75
Viral hepatitis and ABO blood groups. Virologie (1976) 0.75
[Dynamics of interferon in the rhinopharyngeal secretions of adults vaccinated with the NIVGRIP inactivated influenza vaccine by the nasal route]. Virologie (1986) 0.75
The relationship between HLA-B45 and B* 5002 in the five major U.S. population groups. Tissue Antigens (2000) 0.75
Beta2-microglobulin excretion and autoimmune phenomena in endemic Balkan nephropathy. Med Interne (1978) 0.75
[Hepatitis beta-antigen titer and subtypes of acute and chronic hepatitis]. Acta Biol Med Ger (1975) 0.75
Immunological study of liver diseases in diabetics. Med Interne (1979) 0.75
ABO blood groups and HBs AG subtypes and titers in healthy carriers. Vox Sang (1977) 0.75
[The humoral and cell-mediated immune response induced by the NIVGRIP inactivated influenza vaccine]. Virologie (1989) 0.75
Characterization of an HLA-B62 variant (B*1538) exhibiting an additional B52 serologic reactivity. Tissue Antigens (1997) 0.75
[Prevention of some respiratory virus diseases with aerosols. II. Effectiveness of interferon and vaccine in influenzal infection]. Stud Cercet Inframicrobiol (1967) 0.75
Interleukin-2 can induce proliferation of leukemic B-cells in prolymphocytic leukemia. Eur J Haematol (1987) 0.75
Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Virologie (1985) 0.75
Preliminary data on the prevalence of HBe antigen. Virologie (1979) 0.75
Antialbumin agglutinins in HB8Ag-negative hepatic patients. Gastroenterology (1980) 0.75
Novel HLA-A and HLA-B alleles. Tissue Antigens (1998) 0.75
[Study of Australia antigen in chronic hepatitis, hepatic cirrhosis and acute hepatitis cured without defect]. Med Interna (Bucur) (1973) 0.75
Some immunological features in asymptomatic HBsAg carriers. Virologie (1978) 0.75
Preparation of anti-HBs immune serum in the sheep. Virologie (1977) 0.75
An immunological hypothesis for plasma protein catabolism. Mech Ageing Dev (1981) 0.75
Diversity of the anti-HBc response and its correlations with other immunological parameters in asymptomatic HBsAg carriers. Virologie (1978) 0.75
[Arterial and venous thromboses in patients with cryoglobulinemia]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1978) 0.75
[Serum alpha fetoproteins (AFP) and immunologic reactivity in chronic liver diseases]. Physiologie (1980) 0.75
Twelve novel HLA-B*15 alleles carrying previously observed sequence motifs are placed into B*15 subgroups. Tissue Antigens (2001) 0.75
Low-dose cladribine for symptomatic hairy cell leukaemia. Br J Haematol (1995) 0.75
[Significance of anti-albumin antibodies in chronic liver disease]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1978) 0.75
[Evaluation of immuno-serological tests as related to the clinical form of chronic hepatitis]. Physiologie (1977) 0.75
Autoantibodies to thymic epithelial cells in HDV infection. Prog Clin Biol Res (1987) 0.75
[Prevalence of autoantibodies in chronic coronary insufficiency]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1976) 0.75
[The virological study of a certified focus of acute respiratory diseases in a half-closed community]. Rev Roum Virol (1991) 0.75
Reaction spectrum of human HBs antibodies. Rev Roum Virol (1974) 0.75
[Splenectomy in chronic hepatitis with an autoimmune component]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir (1979) 0.75
Red cell agglutination for HBsAg detection. Virologie (1978) 0.75
DRB3 alleles with variations in the annealing sites of commonly used amplification primers. Tissue Antigens (2000) 0.75
Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients. Scand J Infect Dis (1999) 0.75
B-cell chronic lymphocytic leukaemia with aberrant expression of CD8 antigen. Eur J Haematol (1987) 0.75
[Role of immunological studies in the diagnosis of chronic hepatopathies]. Med Interna (Bucur) (1973) 0.75
Reactivity of sera from patients with liver disease with glutaraldehyde-treated erythrocytes: role for false positive results in hemagglutination tests. J Immunol Methods (1984) 0.75
Influenza vaccination by nasal route in a semi-closed community. Virologie (1980) 0.75
HBs antigen and blood glucose concentration. Med Interne (1980) 0.75
[Similarities and differences of the AgHB+ and AgHB- forms of aggressive chronic hepatitis]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1977) 0.75
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor. Ann Oncol (1995) 0.75
[Treatment with ACTH in the myasthenic syndrome with an immunological substratum]. Neurol Psihiatr Neurochir (1974) 0.75
Correlation between cytomegalovirus and toxoplasma gondii serology and lymphocyte phenotypes in peripheral blood and cord blood. Scand J Infect Dis (1989) 0.75
Alteration of T lymphocyte subpopulations in Swedish hemophiliacs. Scand J Haematol Suppl (1984) 0.75
Effect of vitamin A and C overdoses on formation of influenza HAI antibodies in the mouse. Virologie (1976) 0.75
Some particularities of hepatitis B-antigen subdeterminants. Med Microbiol Immunol (1975) 0.75
Incidence of hepatitis B surface antigen (HBsAg) in some areas of Romania. Virologie (1977) 0.75
Clarification of HLA-B serologically ambiguous types by automated DNA sequencing. Tissue Antigens (1998) 0.75